Combining frequency specific microcurrent and color therapy in the treatment of macular degeneration

Two alternative therapies are frequency-specific microcurrent (FSM) and color therapy (CT). When used together, they have a synergistic effect in slowing the progression and, in some cases, reversing macular degeneration.

by Dr. Edward C. Kondrot —

Age-related macular degeneration (ARMD) is the most common cause of irreversible blindness in people older than 65. As many as one-third of those past 65 will develop this condition. It is a slow, progressive disease that affects the central area of the retina, called the macula. This location in the retina is responsible for central vision, which provides the greatest detail in our sight.

Laser treatment has been successful in some cases of wet macular degeneration, when the hemorrhage is distant from the fovea (central part of the macula); in many cases, however, laser treatment causes a further loss of vision and destroys healthy retinal tissue.

Two alternative therapies are frequency-specific microcurrent (FSM) and color therapy (CT). When used together, they have a synergistic effect in slowing the progression and, in some cases, reversing macular degeneration. It is important to note that these therapies strengthen and balance retinal tissue — rather than destroy tissue — to improve vision.

Both therapies use frequencies specific to the retina and the pathology. For example, FSM utilizes hundreds of frequencies within the range of .01 to 999 hertz with varying intensities of 20 to 600 micro amps. Each tissue in the body has an individualized frequency. For example, the retina has a frequency of 95 hertz and the macula 137 hertz. Each pathology also has a frequency. Hemorrhage has a frequency of 18 hertz and edema is 14 hertz. Using these specific frequencies drives the energy into the area needing tissue repair.

In color therapy, light of a specific wavelength is directed into the eye, which affects the autonomic nervous system and the endocrine system. Evidence shows that disease is caused by an imbalance in these systems. Just like in FSM, the light wavelength selected is based on the location and type of pathology in the eye.

Published data from the 73-year-old College of Syntonics indicates that certain frequencies of blue-green light can improve vision in patients with macular degeneration and certain frequencies of green light can reduce pressure in patients with glaucoma. The key phrase here is “certain frequencies.” Each color can have a myriad of frequencies and the task is to identify the frequency that best resonates with the disease. As with FSM, the success of color therapy depends on selecting the proper frequency for the patient.

Edward Kondrot, M.D.(H), CCH, DHt, is a board-certified ophthalmologist and certified homeopathic doctor in practice in Phoenix and Sedona, Ariz. He is the author of Healing the Eye the Natural Way: Alternative Medicine and Macular Degeneration and Microcurrent Stimulation: Miracle Eye Cure. www.healingtheeye.com, 602-631-4504 or 1-800-430-9328.

Reprinted from AzNetNews, Volume 24, Number 5, October/November 2005.